Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;299(10):105254.
doi: 10.1016/j.jbc.2023.105254. Epub 2023 Sep 14.

Anti-InlA single-domain antibodies that inhibit the cell invasion of Listeria monocytogenes

Affiliations

Anti-InlA single-domain antibodies that inhibit the cell invasion of Listeria monocytogenes

Taichi Yamazaki et al. J Biol Chem. 2023 Oct.

Abstract

Listeriosis, caused by infection with Listeria monocytogenes, is a severe disease with a high mortality rate. The L. monocytogenes virulence factor, internalin family protein InlA, which binds to the host receptor E-cadherin, is necessary to invade host cells. Here, we isolated two single-domain antibodies (VHHs) that bind to InlA with picomolar affinities from an alpaca immune library using the phage display method. These InlA-specific VHHs inhibited the binding of InlA to the extracellular domains of E-cadherin in vitro as shown by biophysical interaction analysis. Furthermore, we determined that the VHHs inhibited the invasion of L. monocytogenes into host cells in culture. High-resolution X-ray structure analyses of the complexes of VHHs with InlA revealed that the VHHs bind to the same binding site as E-cadherin against InlA. We conclude that these VHHs have the potential for use as drugs to treat listeriosis.

Keywords: InlA; Listeria monocytogenes; isothermal titration calorimetry (ITC); listeriosis; protein-protein interaction; single-domain V(H)H antibody; surface plasmon resonance (SPR).

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Figures

Figure 1
Figure 1
Selection of anti-InlA VHH antibodies.A, phage ELISA analysis of single clones from phage display library. ELISA assays were performed twice on each clone (first and second). The asterisks mark clones selected for sequence analysis (total 28 clones). B, SPR analysis of the interaction between InlA and vhh10. C, SPR analysis of the interaction between InlA and vhh24. D, SPR analysis of the interaction between InlA and D3-L11. The color lines are the raw data and the black lines are the fitting curves in SPR. E, ITC analysis of the interaction between InlA and vhh10. F, ITC analysis of the interaction between InlA and vhh24. G, ITC analysis of the interaction between InlA and D3-L11. ITC, isothermal titration calorimetry; SPR, surface plasmon resonance.
Figure 2
Figure 2
Anti-InlA VHHs inhibit the interaction between InlA and EC12. ITC profiles of the interaction of InlA and EC12 (A) in the absence of VHH, (B) in the presence of vhh10, and (C) in the presence of vhh24. EC, extracellular cadherin; ITC, isothermal titration calorimetry.
Figure 3
Figure 3
Anti-InlA VHHs inhibit invasion of L. monocytogenes into human cells in a dose-dependent manner.A, percentages of bacterial cells adhered to Caco-2 cells in the presence of vhh10 and vhh24 at indicated concentrations. B, percentage of bacterial cells inside Caco-2 cells in the presence of vhh10 and vhh24 at indicated concentrations. C, percentages of VHH pretreated bacterial cells adhered to Caco-2 cells. D, percentages of VHH pretreated bacterial cells inside Caco-2 cells. Anti-lysozyme VHH antibody D3-L11 was used as a control. All values are expressed as mean ± S.D. One-way ANOVA, followed by Dunnett's test was used to evaluate differences compared to control. ∗∗∗∗ p < 0.0001, ∗∗∗ p < 0.001.
Figure 4
Figure 4
Three dimensional structures of InlA in complex with the EC12 domains of E-cadherin.A, InlA (gray) in complex with EC12 (green). B, structure of InlA with EC12 contact interface in green. C, interactions in the InlA-EC12 complex. InlA and EC12 are drawn as cartoon displays in gray and green, respectively. Ca2+ is depicted as blue spheres. Structures were created with Pymol software (Version 2.3.2, Schrödinger, LLC). EC, extracellular cadherin.
Figure 5
Figure 5
Interactions in the InlA-VHHs complex.A, InlA (gray) in complex with vhh10 (magenta). B, structure of InlA with vhh10 contact interface in magenta color. C, InlA (gray) in complex with vhh24 (orange). D, structure of InlA with vhh24 contact interface in orange. E, overlay of complexes. The LRR region of InlA is shown in beige color. All of the structures were created with Pymol software (Version 2.3.2, Schrödinger, LLC).
Figure 6
Figure 6
Three dimensional structures of InlA in complex with the VHHs.A, interactions at CDR-H1, CDR-H2, and CDR-H3 in the InlA-vhh10 complex. InlA, vhh10, and CDR are drawn as cartoon displays in gray, magenta, and light purple, respectively. B, interactions at CDR-H1, CDR-H2, and CDR-H3 in the InlA-vhh24 complex. InlA, vhh24, and CDR are drawn as cartoon displays in gray, orange, and light purple, respectively. Structures were created with Pymol software (Version 2.3.2, Schrödinger, LLC). CDR, complementarity-determining region.

Similar articles

Cited by

References

    1. Allerberger F. Listeria: growth, phenotypic differentiation and molecular microbiology. FEMS Immunol. Med. Microbiol. 2003;35:183–189. - PubMed
    1. Hamon M., Bierne H., Cossart P. Listeria monocytogenes: a multifaceted model. Nat. Rev. Microbiol. 2006;4:423–434. - PubMed
    1. Bonazzi M., Lecuit M., Cossart P. Listeria monocytogenes internalin and E-cadherin: from structure to pathogenesis. Cell. Microbiol. 2009;11:693–702. - PubMed
    1. Dussurget O., Pizarro-Cerda J., Cossart P. Molecular determinants of Listeria monocytogenes virulence. Annu. Rev. Microbiol. 2004;58:587–610. - PubMed
    1. Madjunkov M., Chaudhry S., Ito S. Listeriosis during pregnancy. Arch. Gynecol. Obstet. 2017;296:143–152. - PubMed

LinkOut - more resources